Ask the expert: Triple-negative breast cancer
Triple-negative breast cancer (TNBC) makes up 15 to 20 percent of all breast cancer diagnoses, and disproportionately affects young, Black, and Latinx communities who often face barriers to information and care. TNBC can be misunderstood and as a person with triple-negative breast cancer, you may have specific concerns regarding your diagnosis and care.
During this webinar, oncologist, Rita Nanda, MD, will answer your questions about early stage and metastatic TNBC. This free, 75-minute program will be entirely dedicated to Q&A so you can get answers to your questions about symptoms, side-effects, treatment options and more.
Join Dr. Nanda and LBBC on February 22 for trusted medical information to help you feel confident to make the best decisions for you.
ASL interpreting will be offered during the live webinar for anyone who may need it. If you are interested in utilizing the ASL interpreting services, please email us at [email protected].
About our expert:
Rita Nanda, MD, is an associate professor of medicine and director of the breast medical oncology program at The University of Chicago. Her research interests include identifying new treatments for breast cancer, with a focus on triple-negative disease. She leads the University of Chicago’s clinical and translational breast cancer research efforts and serves as a principal investigator for the Translational Breast Cancer Research Consortium (TBCRC) and the ISPY2 Clinical Trial Network. She is a member of several professional organizations, including the American Society of Clinical Oncology, the American Association of Cancer Research, and the Society for Immunotherapy of Cancer. Read more.